Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.30
-0.38%
Mkt Cap $833.98M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+353.1%
Consensus $5.89 vs current $1.30
NASDAQ·Healthcare·Biotechnology
$1.30
-0.38%
Mkt Cap $833.98M
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+353.1%
Consensus $5.89 vs current $1.30